Tell us a little bit about yourself!
My name is Dr. Lacramioara Ivanciu; I’m a resident assistant professor of pediatrics in the Perelman School of Medicine at the University of Pennsylvania. In 2010, when I was a postdoctoral…
The demographic disparities between WCNHs and other participants in the CVR are critical and emphasize the need to focus on correlations between known social determinants of health and self-reported health outcomes and quality-of-life information.…
Sara L. Schwartz is a Clinical Associate Professor at the University of Southern California Suzanne Dworak-Peck School of Social Work. Her research portfolio examines experiences of isolation in diverse settings and communities such as public child…
Diagnostic Considerations for Optimizing Successful Outcomes in HLH
Wednesday, November 2, 2022
11:00 AM PT /12:00 PM MT / 1:00 PM CT / 2:00 PM ET
Guest Educator:
Ashish Kumar, MD, PhD
Professor of…
Current and Emerging Perspectives in Chronic Immune Thrombocytopenia (ITP)
Wednesday, November 9, 2022
11:00 AMPT /12:00 PM MT / 1:00 PM CT / 2:00 PM ET
Guest Educator:
Shruti Chaturvedi, MD, MBBS, MS …
VWD and Joint Bleeds
Speaker(s): Prof. H.C.J. Eikenboom, MD PhD
Leiden University Medical Center
What is a joint bleed, and how is it caused? How can a joint bleed present itself in a person with VWD? How do you know if you are…
Giving Tuesday Highlight & The Importance of End-of-Year Giving
Speaker(s): Maureen Parsons
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the…
Disponible en españolNBDF’s Medical and Scientific Advisory Council (MASAC) issues recommendations and advisories on treatment, research, and other general health concerns for the bleeding disorders community. MASAC is composed of medical…
These are exciting times in bleeding disorders research, with new treatment options on the horizon. Come learn about the latest results of various phases of clinical trials on gene therapies and innovative therapies, and other new treatment options…
The bleeding disorders community is witnessing a proliferation in the number and types of therapies available to treat hemophilia. This will be a patient-moderated session with three medical experts to discuss innovation, safety and the importance…